flavanone has been researched along with Atherosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caimari, A; Crescenti, A; Del Bas, JM; Domenech-Coca, C; Escoté, X; Mas-Capdevila, A; Teichenne, J | 1 |
| Cui, JR; Du, GH; Fang, LH; Feng, XE; Li, QS; Shi, L | 1 |
1 review(s) available for flavanone and Atherosclerosis
| Article | Year |
|---|---|
Effect of Hesperidin on Cardiovascular Disease Risk Factors: The Role of Intestinal Microbiota on Hesperidin Bioavailability.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Biological Availability; Cardiovascular Diseases; Cardiovascular System; Citrus; Dysbiosis; Dyslipidemias; Flavanones; Gastrointestinal Microbiome; Hesperidin; Humans; Obesity; Risk Factors | 2020 |
1 other study(ies) available for flavanone and Atherosclerosis
| Article | Year |
|---|---|
Synthesis and biological activity of flavanone derivatives.
Topics: Antineoplastic Agents; Atherosclerosis; Cell Line; Cell Line, Tumor; Cell Proliferation; Cytoprotection; Endothelial Cells; Flavanones; Humans; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neoplasms; Protein-Tyrosine Kinases; Structure-Activity Relationship | 2010 |